Digital
June 25-26, 2020

3rd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress - Virtual Event (Time Zone - ET)

45+
Speakers
200+
Attendees
4
Networking Hours
5+
Sessions

Due to growing concerns about COVID-19, the 3rd Annual MarketsandMarkets Next Gen IO Congress is going fully virtual this year. We are disappointed that we are not able to come together in person in June for this event, but we are so thrilled to see you on an online platform. We are working together to create a virtual conference that will be beneficial and engaging for speakers, attendees and sponsors/exhibitors.

See the Post Show report of our 2nd Annual here

Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT

Key Highlights

  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
  • Monoclonal Antibody & Cellular Therapy
  • Neoantigens in personalized Cancer Immunotherapy
  • Biomarkers and Cancer Vaccines
  • Developments in CAR-T Cellular Therapy
  • Oncolytic Viral Therapy & Personalized Medicine
  • Engineering Cellular Therapies Beyond Traditional Tumor Antigens
  • Combination Therapies in I/O

Why attend Virtual?

  • Exclusive Virtual event to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive Q&A sessions with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Board Member, MarketsandMarkets
Roy Baynes
Roy Baynes
Senior Vice President and Head Global Clinical Development, Chief Medical Officer, , Merck Research Laboratories
Mithun Khattar
Mithun Khattar
Immuno-Oncology Lead, Takeda Oncology
Stefan Glueck
Stefan Glueck
Ex- Vice President, Global Head Franchise Oncology, Regeneron
Nuzhat Pathan
Nuzhat Pathan
Director, Early Development, Translational and Immuno-Oncology, Pfizer
Philip Arlen
Philip Arlen
Chief Scientific Officer, Senior Vice President, Diverse Biotech
Nathaniel Wang
Nathaniel Wang
Oncology Vaccines Project Leader, Janssen, Pharmaceutical Companies of Johnson and Johnson
Shailesh Maingi
Shailesh Maingi
Founder and CEO, Kineticos Life Sciences
SPONSORS
Gold
example-image

BIOCYTOGEN

example-image

Applied BioMath

example-image

QIAGEN

Silver
example-image

PhenoSwitch Bioscience

Sponsors & Exhibitors
example-image

PromoCell

example-image

TransCure bioServices

example-image

BerGenBio

example-image

Imaging Endpoints

example-image

Q2 Solutions

example-image

CellGenix

example-image

Thermo Fisher Scientific

example-image

PHC Group

example-image

PHC Group

example-image

PHC Group

example-image

Proteome Sciences

example-image

Eppendorf

example-image

Cook Regentec

example-image

BioIVT

example-image

NeoGenomics

PAST EVENT GALLERY